AliceYHoMD

Radiation Oncology • New York, NY

Breast Cancer

Director of Breast Service and Breast Research Program, Radiation Oncology

Join to view full profile

Dr. Ho is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ho's full profile

Already have an account?

Office
1275 York Avenue
New York, NY 10065

Education & Training

Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 2003 - 2007
Westchester Medical CenterInternship, Internal Medicine, 2002 - 2003
Tufts University School of MedicineClass of 2002

Certifications & Licensure

FL State Medical License 2024 - 2026
AZ State Medical License 2024 - 2025
CA State Medical License 2016 - 2025
NY State Medical License 2004 - 2025
NC State Medical License 2022 - 2024
NH State Medical License 2021 - 2024
ME State Medical License 2020 - 2023
MA State Medical License 2018 - 2022
American Board of Radiology Radiation Oncology
Join now to see all

Clinical Trials

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Start of enrollment: 2010 May 11
Completed
Not Applicable
Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer Start of enrollment: 2010 Sep 01
Active, not recruiting
Phase 2
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma Start of enrollment: 2018 Apr 01
Active, not recruiting
Not Applicable
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients Start of enrollment: 2019 Jul 11
Recruiting
Phase 1
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer Start of enrollment: 2021 Jul 21
Recruiting
Phase 2
Roles: Principal Investigator
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) Start of enrollment: 2020 Dec 16
Recruiting
Phase 2
Roles: Sponsor-Investigator
Join now to see all

Publications & Presentations

PubMed

106 citations
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.
Alice Y. Ho, Christopher A. Barker, Brittany Arnold, Simon N. Powell, Zishuo I. Hu
Cancer. 2020-02-15
74 citations
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2...
Ana P. Kiess, Heather L. McArthur, Kathleen M. Mahoney, Sujata Patil, Patrick G. Morris
Cancer. 2012-04-15
26 citations
Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumors: A Narrative Review.
Franziska Hauth, Alice Y. Ho, Soldano Ferrone, Dan G. Duda
JAMA Oncology. 2021-07-01

Press Mentions

Breast Cancer: Radiation for Certain Patients 65 and Older May Not Affect Their Survival, New Study SuggestsFebruary 17th, 2023
Certain Breast Cancer Patients 65 and Older May Be Able to Go Without Radiation Therapy, New Study Suggests | CNNFebruary 17th, 2023
Missing Evidence: Drug-Radiotherapy Combinations in Breast CancerOctober 25th, 2022
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member